Literature DB >> 3280179

Immunohistochemical demonstration of migration inhibitory factor (MIF) in experimental allergic contact dermatitis.

U Malorny1, J Knop, G Burmeister, C Sorg.   

Abstract

The kinetics of appearance of MIF+ cells was investigated in experimental contact dermatitis using a monoclonal antibody (7D10) against murine MIF which was reacted with cryostat sections of tissues and detected by the indirect immunoperoxidase test. Four groups of BALB/c mice were investigated: (1) sensitized with 2,4-dinitrofluorobenzene (DNFB); (2) unsensitized controls; (3) tolerized; (4) unsensitized. A challenge dose of DNFB was applied to the ear of animals of groups 1-3 and of croton oil to those of group 4. Three phases could be distinguished in group 1: (a) an initial vascular and exudative reaction; (b) an early cellular phase; and (c) a late cellular phase. At zero time rarely any T lymphocytes (Lyt 1+; Lyt 2+) were seen in all four groups. Within less than 30 min venous endothelial cells became strongly MIF+. This was followed by an influx of monocytes/macrophages reaching a maximum of 72 h in group 1 and a slight peak at 12 h in groups 2 and 3. At 16-24 h in all groups the endothelial reaction weakened while many 7D10+ macrophages appeared in group 1. By double-labelling it was shown that lymphocytes were 7D10-. The influx of lymphocytes, part of which carried the T cell receptor, began at 12 h, reaching a maximum at 72 h in group 1. In groups 2 and 3 only a weak lymphocytic infiltrate developed which declined at 24 h. Group 4 developed an inflammatory reaction after the initial phase with similar kinetics as in group 1. The data suggest that an immune inflammatory reaction is preceded by a nonspecific reaction of the vascular endothelium and the mononuclear phagocytic system and that MIF is playing a central role in these events.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280179      PMCID: PMC1541650     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.

Authors:  A Scheynius; L Klareskog; U Forsum
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

2.  Immunohistological analysis of delayed-type hypersensitivity in man.

Authors:  L W Poulter; G J Seymour; O Duke; G Janossy; G Panayi
Journal:  Cell Immunol       Date:  1982-12       Impact factor: 4.868

3.  Allergic and toxic contact dermatitis: inflammatory cell subtypes in epicutaneous test reactions.

Authors:  S Reitamo; E Tolvanen; Y T Konttinen; K Käyhkö; L Förström; O P Salo
Journal:  Br J Dermatol       Date:  1981-11       Impact factor: 9.302

4.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

5.  Functional characteristics of murine macrophages responding to migration inhibitory factors.

Authors:  E Michels; W Stenzinger; C Sorg
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

6.  Expression of antigen-specific, major histocompatibility complex-restricted receptors by cortical and medullary thymocytes in situ.

Authors:  A G Farr; S K Anderson; P Marrack; J Kappler
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

7.  Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in man.

Authors:  A Scheynius; T Fischer; U Forsum; L Klareskog
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

Review 8.  Selection of the delayed hypersensitivity T effector and T suppressor cell response by antigen-presenting macrophages.

Authors:  J Knop; U Malorny; E Michels; C Sorg
Journal:  Immunobiology       Date:  1984-12       Impact factor: 3.144

9.  Detection of macrophage migration inhibitory factor by monoclonal antibody in Sézary syndrome.

Authors:  C Neumann; R Schlegel; F Steckel; C Sorg
Journal:  J Invest Dermatol       Date:  1987-06       Impact factor: 8.551

10.  Immune cell populations in cutaneous delayed-type hypersensitivity.

Authors:  J L Platt; B W Grant; A A Eddy; A F Michael
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  6 in total

1.  Detection of migration inhibitory factor (MIF) by a monoclonal antibody in the microvasculature of inflamed skin.

Authors:  R S Gómez; T L Diepgen; C Neumann; C Sorg
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues.

Authors:  G Zwadlo; J Brüggen; G Gerhards; R Schlegel; C Sorg
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

3.  Early time course of recruitment of immune surveillance in human skin after chemical provocation.

Authors:  P S Friedmann; I Strickland; A A Memon; P M Johnson
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

4.  The severity of irritant contact dermatitis in various strains of mice correlates with endothelial expression of migration inhibitory factor (MIF).

Authors:  M Goebeler; J Gutwald; J Roth; C Sorg
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

5.  Circulating monocyte migration inhibitory factor in serum of Graves' ophthalmopathy patients: a parameter for disease activity?

Authors:  R van der Gaag; L Broersma; M P Mourits; L Koornneef; W M Wiersinga; M P Prummel; A Berghout
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

6.  The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin.

Authors:  G Papaccio; M Latronico; G Chieffi Baccari
Journal:  Cell Tissue Res       Date:  1994-09       Impact factor: 5.249

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.